BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8161528)

  • 1. Selective inhibition of mammalian lanosterol 14 alpha-demethylase by RS-21607 in vitro and in vivo.
    Swinney DC; So OY; Watson DM; Berry PW; Webb AS; Kertesz DJ; Shelton EJ; Burton PM; Walker KA
    Biochemistry; 1994 Apr; 33(15):4702-13. PubMed ID: 8161528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azalanstat (RS-21607), a lanosterol 14 alpha-demethylase inhibitor with cholesterol-lowering activity.
    Burton PM; Swinney DC; Heller R; Dunlap B; Chiou M; Malonzo E; Haller J; Walker KA; Salari A; Murakami S
    Biochem Pharmacol; 1995 Aug; 50(4):529-44. PubMed ID: 7646560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lanosterol 14 alpha-demethylase (P45014DM): effects of P45014DM inhibitors on sterol biosynthesis downstream of lanosterol.
    Tuck SF; Patel H; Safi E; Robinson CH
    J Lipid Res; 1991 Jun; 32(6):893-902. PubMed ID: 1940622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol biosynthesis from lanosterol: development of a novel assay method and characterization of rat liver microsomal lanosterol delta 24-reductase.
    Bae SH; Paik YK
    Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):609-16. PubMed ID: 9291139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different substrate specificities of lanosterol 14a-demethylase (P-45014DM) of Saccharomyces cerevisiae and rat liver for 24-methylene-24,25-dihydrolanosterol and 24,25-dihydrolanosterol.
    Aoyama Y; Yoshida Y
    Biochem Biophys Res Commun; 1991 Aug; 178(3):1064-71. PubMed ID: 1872829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of hepatic cholesterol biosynthesis. Effects of a cytochrome P-450 inhibitor on the formation and metabolism of oxygenated sterol products of lanosterol.
    Iglesias J; Gibbons GF
    Biochem J; 1989 Dec; 264(2):495-502. PubMed ID: 2604729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of a cytochrome P450 isozyme catalyzing lanosterol 14 alpha-demethylation (P45014DM) in hamster liver.
    Sekigawa Y; Fukuhara M; Sonoda Y; Sato Y
    Lipids; 1995 Dec; 30(12):1067-73. PubMed ID: 8614296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase by 15 alpha-fluorolanost-7-en-3 beta-ol. A mechanism-based inhibitor of cholesterol biosynthesis.
    Trzaskos JM; Magolda RL; Favata MF; Fischer RT; Johnson PR; Chen HW; Ko SS; Leonard DA; Gaylor JL
    J Biol Chem; 1993 Oct; 268(30):22591-9. PubMed ID: 7693673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deformylation of 32-oxo-24,25-dihydrolanosterol by the purified cytochrome P-45014DM (lanosterol 14 alpha-demethylase) from yeast evidence confirming the intermediate step of lanosterol 14 alpha-demethylation.
    Aoyama Y; Yoshida Y; Sonoda Y; Sato Y
    J Biol Chem; 1989 Nov; 264(31):18502-5. PubMed ID: 2509459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of 32-hydroxy-24,25-dihydrolanosterol by purified cytochrome P-45014DM from yeast. Evidence for contribution of the cytochrome to whole process of lanosterol 14 alpha-demethylation.
    Aoyama Y; Yoshida Y; Sonoda Y; Sato Y
    J Biol Chem; 1987 Jan; 262(3):1239-43. PubMed ID: 3543000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of mammalian lanosterol 14 alpha-demethylase: a possible strategy for cholesterol lowering.
    Walker KA; Kertesz DJ; Rotstein DM; Swinney DC; Berry PW; So OY; Webb AS; Watson DM; Mak AY; Burton PM
    J Med Chem; 1993 Jul; 36(15):2235-7. PubMed ID: 8340925
    [No Abstract]   [Full Text] [Related]  

  • 12. 7-Oxo-24,25-dihydrolanosterol: a novel lanosterol 14 alpha-demethylase (P-45014DM) inhibitor which blocks electron transfer to the oxyferro intermediate.
    Aoyama Y; Yoshida Y; Sonoda Y; Sato Y
    Biochim Biophys Acta; 1987 Dec; 922(3):270-7. PubMed ID: 3318933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate-based inhibitors of lanosterol 14 alpha-methyl demethylase: II. Time-dependent enzyme inactivation by selected oxylanosterol analogs.
    Trzaskos JM; Fischer RT; Ko SS; Magolda RL; Stam S; Johnson P; Gaylor JL
    Biochemistry; 1995 Aug; 34(30):9677-81. PubMed ID: 7626637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol biosynthesis from lanosterol: differential inhibition of sterol delta 8-isomerase and other lanosterol-converting enzymes by tamoxifen.
    Cho SY; Kim JH; Paik YK
    Mol Cells; 1998 Apr; 8(2):233-9. PubMed ID: 9638657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of meiosis-activating sterols in rat oocyte maturation: effects of specific inhibitors and changes in the expression of lanosterol 14alpha-demethylase during the preovulatory period.
    Vaknin KM; Lazar S; Popliker M; Tsafriri A
    Biol Reprod; 2001 Jan; 64(1):299-309. PubMed ID: 11133687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lanosterol 14 alpha-methyl demethylase. Isolation and characterization of the third metabolically generated oxidative demethylation intermediate.
    Fischer RT; Trzaskos JM; Magolda RL; Ko SS; Brosz CS; Larsen B
    J Biol Chem; 1991 Apr; 266(10):6124-32. PubMed ID: 2007571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate-based inhibitors of lanosterol 14 alpha-methyl demethylase: I. Assessment of inhibitor structure-activity relationship and cholesterol biosynthesis inhibition properties.
    Trzaskos JM; Ko SS; Magolda RL; Favata MF; Fischer RT; Stam SH; Johnson PR; Gaylor JL
    Biochemistry; 1995 Aug; 34(30):9670-6. PubMed ID: 7626636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectivity of isoprenoid-containing imidazole antifungal compounds for sterol 14-demethylase P450 (P450(14)DM) and 7-ethoxycoumarin O-deethylase P450 of rat liver microsomes.
    Ito T; Aoyama Y; Ishida K; Kudoh M; Hori K; Tsuchiya S; Yoshida Y
    Biochem Pharmacol; 1994 Oct; 48(8):1577-82. PubMed ID: 7980623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical basis for a cholesterol-lowering activity of 2-[2"-(1",3"-dioxolane)]-2-methyl-4-(2'-oxo-1'-pyrrolidinyl)-6- nitro-2H-1-benzopyran (SKP-450), a novel antihypertensive agent.
    Lee EY; Lim DM; Yoo SE; Kim DK; Paik YK
    Biochem Pharmacol; 1999 Mar; 57(5):579-82. PubMed ID: 9952322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsomal enzymes of cholesterol biosynthesis. Purification of lanosterol 14 alpha-methyl demethylase cytochrome P-450 from hepatic microsomes.
    Trzaskos J; Kawata S; Gaylor JL
    J Biol Chem; 1986 Nov; 261(31):14651-7. PubMed ID: 3771545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.